Publikationen in Zusammenarbeit mit Forschern von University of Copenhagen (18)

2024

  1. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis

    European Psychiatry, Vol. 66, Núm. 1

2022

  1. CT or Invasive Coronary Angiography in Stable Chest Pain

    New England Journal of Medicine, Vol. 386, Núm. 17, pp. 1591-1602

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis

    Psychological Medicine, Vol. 52, Núm. 8, pp. 1569-1577

2021

  1. Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study

    European Radiology, Vol. 31, Núm. 3, pp. 1471-1481

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis

    Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 823-833

  2. Erratum: Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain (Health Qual Life Outcomes (2020) 18: 140 DOI: 10.1186/s12955-020-01312-4)

    Health and Quality of Life Outcomes

  3. Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain

    Health and Quality of Life Outcomes, Vol. 18, Núm. 1

  4. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

    Genetics in Medicine, Vol. 22, Núm. 9, pp. 1478-1488

2019

  1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    The Lancet, Vol. 393, Núm. 10184, pp. 1937-1947

  2. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

  3. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

2018

  1. Does arterial hypertension influence the onset of Huntington’s disease?

    PLoS ONE, Vol. 13, Núm. 5

  2. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial

    European Radiology, Vol. 27, Núm. 7, pp. 2957-2968